Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ESRRA | P11474 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3688027 | 1.00 | HIF1A (0.52) | HIF1AKDM4EHPGDTLR9RAB9A | |
| SCHEMBL3697793 | 0.92 | HIF1A (0.51) | HIF1AKDM4EHPGDTLR9RAB9A | |
| SCHEMBL3697791 | 0.92 | HIF1A (0.51) | HIF1AKDM4EHPGDTLR9RAB9A | |
| SCHEMBL3687980 | 0.91 | HIF1A (0.52) | HIF1ARAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL3687974 | 0.91 | HIF1A (0.52) | HIF1ARAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL3683435 | 0.91 | HIF1A (0.64) | HIF1AHPGDRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL3683433 | 0.91 | HIF1A (0.64) | HIF1AHPGDRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL3686962 | 0.90 | HIF1A (0.63) | HIF1AKDM4EHPGDTLR9RAB9A | |
| SCHEMBL3687946 | 0.90 | HIF1A (0.51) | HIF1AHPGDRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL3687943 | 0.90 | HIF1A (0.51) | HIF1AHPGDRAB9ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231591-B1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORP (KR) | 2015-02-11 | — | — | EP | claimed |
| US-8410302-B2 | Methoxyimino compounds and fungicide composition comprising same | KYUNG NONG CORPORATION (KR) | 2013-04-02 | — | — | US | claimed |
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-25 | — | — | US | claimed |
| EP-2231591-A2 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | Kyung Nong Corporation (KR) | 2010-09-29 | — | — | EP | claimed |
| WO-2009072837-A2 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2009-06-11 | — | — | WO | claimed |
| EP-2231591-B1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORP (KR) | 2015-02-11 | — | — | EP | disclosed |
| US-8410302-B2 | Methoxyimino compounds and fungicide composition comprising same | KYUNG NONG CORPORATION (KR) | 2013-04-02 | — | — | US | disclosed |
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | CYP51A1, MSMO1, MTMR1 | HIF1A 3994/4885KDM4E 143/4885HPGD 4555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.